Company / Depreciation & Amortization
Progyny Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$4.9M
FY2025
5-year range
$1.3M / $4.9M
FY2021-FY2025
Trend
+55.8%
vs FY2024
Sector context
#126 of 135
Health Care
What the data says
Among 135 Health Care companies, Progyny is in the top 7% for depreciation & amortization. Depreciation & Amortization has increased for 4 consecutive years, from $1M in FY2021 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +21.0%.
Increased from $2M to $5M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +45.7%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 135This company $4.9M Sector average $334.5M
▼
-98.5% below sector average
Key checks
Key Insights
- Progyny's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 55.8% year-over-year.
- Ranks #126 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.9M | +55.8% |
| FY2024 | $3.2M | +39.2% |
| FY2023 | $2.3M | +42.5% |
| FY2022 | $1.6M | +23.1% |
| FY2021 | $1.3M | -31.7% |
| FY2020 | $1.9M | -10.6% |
| FY2019 | $2.1M | +13.3% |
| FY2018 | $1.9M | +20.8% |
| FY2017 | $1.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026